{"id":"https://openalex.org/W7225342289","doi":"https://doi.org/10.1097/wco.0000000000001524","title":"Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations","display_name":"Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225342289","doi":"https://doi.org/10.1097/wco.0000000000001524","pmid":"https://pubmed.ncbi.nlm.nih.gov/43001484"},"language":"en","primary_location":{"id":"doi:10.1097/wco.0000000000001524","doi":"https://doi.org/10.1097/wco.0000000000001524","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wco.0000000000001524","pdf_url":null,"source":{"id":"https://openalex.org/S177945262","display_name":"Current Opinion in Neurology","issn_l":"1350-7540","issn":["1350-7540","1473-6551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Neurology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5143756820","display_name":"Elizabeth Owens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Owens","raw_affiliation_strings":["The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center; Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center; Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160750181","display_name":"Maya S. Chandar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maya S. Chandar","raw_affiliation_strings":["The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center; Durham, North Carolina","University of Miami, Miller School of Medicine, Miami, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center; Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"University of Miami, Miller School of Medicine, Miami, Florida, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004781307","display_name":"Mustafa Khasraw","orcid":"https://orcid.org/0000-0003-3249-9849","observed_orcids":["https://orcid.org/0000-0003-3249-9849"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mustafa Khasraw","raw_affiliation_strings":["The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center; Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center; Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"6","first_page":"571","last_page":"577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.13989999890327454,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioma-immunotherapy","display_name":"glioma immunotherapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8939999938011169},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.6909999847412109},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/h3k27m-mutation","display_name":"H3K27M mutation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.7929999828338623},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9309999942779541},{"id":"https://openalex.org/keywords/immunocytokines","display_name":"immunocytokines","score":0.9679999947547913},{"id":"https://openalex.org/keywords/oncolytic-viruses","display_name":"oncolytic viruses","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glioma-microenvironment","display_name":"glioma microenvironment","score":0.7639999985694885},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6729999780654907},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.5929999947547913},{"id":"https://openalex.org/keywords/myeloid-immunosuppression","display_name":"myeloid immunosuppression","score":0.7900000214576721},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.8040000200271606},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.625},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.866100013256073},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7994999885559082},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7152000069618225},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6814000010490417},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.565500020980835},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5648000240325928},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5597000122070312},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5564000010490417},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4977000057697296},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48080000281333923},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4643000066280365},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4293999969959259},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3682999908924103},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.3483999967575073},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.34049999713897705},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3197000026702881},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.31949999928474426},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.30410000681877136},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28940001130104065},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.27869999408721924},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.27709999680519104},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.25049999356269836}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064987","descriptor_name":"Cell- and Tissue-Based Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/wco.0000000000001524","doi":"https://doi.org/10.1097/wco.0000000000001524","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wco.0000000000001524","pdf_url":null,"source":{"id":"https://openalex.org/S177945262","display_name":"Current Opinion in Neurology","issn_l":"1350-7540","issn":["1350-7540","1473-6551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Neurology","raw_type":"journal-article"},{"id":"pmid:43001484","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43001484","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in neurology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W2596261790","https://openalex.org/W2749747068","https://openalex.org/W2878436114","https://openalex.org/W2904210127","https://openalex.org/W2904803926","https://openalex.org/W2911752971","https://openalex.org/W2913623258","https://openalex.org/W3026551532","https://openalex.org/W3030339055","https://openalex.org/W3107050167","https://openalex.org/W3137406939","https://openalex.org/W3174246647","https://openalex.org/W4210924686","https://openalex.org/W4223897107","https://openalex.org/W4225630787","https://openalex.org/W4286492761","https://openalex.org/W4294684427","https://openalex.org/W4309183974","https://openalex.org/W4311673768","https://openalex.org/W4367673693","https://openalex.org/W4376609298","https://openalex.org/W4377966996","https://openalex.org/W4386923711","https://openalex.org/W4390791001","https://openalex.org/W4392560879","https://openalex.org/W4392779080","https://openalex.org/W4404306023","https://openalex.org/W4404495895","https://openalex.org/W4406150643","https://openalex.org/W4410927251","https://openalex.org/W7118606599","https://openalex.org/W7166862076","https://openalex.org/W7196928464"],"related_works":["https://openalex.org/W4310035827","https://openalex.org/W4308917956","https://openalex.org/W7203986364","https://openalex.org/W7213903312","https://openalex.org/W4399013012","https://openalex.org/W3152818432","https://openalex.org/W2900607737","https://openalex.org/W3029893247","https://openalex.org/W2186905301","https://openalex.org/W4221022657"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"Immunotherapy":[3],"has":[4,12],"transformed":[5],"the":[6,27,66,170,223],"treatment":[7],"of":[8],"many":[9],"malignancies":[10],"but":[11,193],"not":[13],"yet":[14],"produced":[15],"comparable":[16],"improvements":[17],"in":[18,177],"survival":[19],"for":[20,30,84],"patients":[21,86],"with":[22,87],"gliomas.":[23],"This":[24],"review":[25],"examines":[26],"biological":[28],"rationale":[29],"immunotherapy":[31,179],"across":[32,118],"molecularly":[33],"defined":[34],"gliomas,":[35],"lessons":[36],"from":[37],"unsuccessful":[38],"immune":[39,56,185,195,231],"checkpoint":[40],"inhibitor":[41],"trials,":[42],"and":[43,60,97,111,130,151,156,163,189,220,226,230],"emerging":[44],"strategies":[45],"including":[46,95],"vaccines,":[47],"adoptive":[48],"cellular":[49],"therapies,":[50],"bispecific":[51],"T-cell":[52,102,104],"engagers,":[53],"immunocytokines,":[54],"innate":[55],"modulators,":[57],"oncolytic":[58],"viruses,":[59],"approaches":[61,167],"to":[62,168,209],"improve":[63],"delivery":[64],"within":[65],"central":[67],"nervous":[68],"system.":[69],"RECENT":[70],"FINDINGS:":[71],"Randomized":[72],"studies":[73,122],"have":[74],"established":[75],"that":[76,124,184],"programmed":[77],"death-1":[78],"(PD-1)":[79],"blockade":[80],"alone":[81],"is":[82,180],"insufficient":[83],"unselected":[85],"glioblastoma.":[88],"Treatment":[89],"resistance":[90],"reflects":[91],"multiple":[92,213],"interacting":[93],"barriers,":[94],"low":[96],"heterogeneous":[98],"antigen":[99,142],"expression,":[100],"limited":[101],"infiltration,":[103],"dysfunction,":[105],"immunosuppressive":[106],"myeloid":[107],"populations,":[108],"corticosteroid":[109],"exposure,":[110],"treatment-associated":[112],"lymphopenia.":[113],"Importantly,":[114],"these":[115],"features":[116],"differ":[117],"glioma":[119,171,178,191],"subtypes.":[120],"Recent":[121],"demonstrate":[123],"vaccines":[125],"directed":[126],"against":[127],"clonal":[128,215],"IDH1":[129],"H3K27M":[131],"mutations":[132],"can":[133,153,187],"generate":[134],"durable":[135,158,198],"antigen-specific":[136],"immunity,":[137],"while":[138],"locoregionally":[139],"delivered":[140],"chimeric":[141],"receptor":[143],"T":[144],"(CAR-T)":[145],"cells":[146,186,192],"targeting":[147,212],"IL13R\u03b12,":[148],"EGFR/EGFRvIII,":[149],"GD2,":[150],"B7-H3":[152],"produce":[154],"rapid":[155],"occasionally":[157],"tumor":[159,199,229],"regression.":[160],"Oncolytic":[161],"viruses":[162],"immunocytokines":[164],"provide":[165],"complementary":[166],"remodeling":[169],"microenvironment.":[172],"SUMMARY:":[173],"The":[174],"principal":[175],"challenge":[176],"no":[181],"longer":[182],"demonstrating":[183],"recognize":[188],"kill":[190],"converting":[194],"recognition":[196],"into":[197],"control.":[200],"Future":[201],"progress":[202],"will":[203],"likely":[204],"depend":[205],"on":[206],"matching":[207],"therapy":[208],"molecular":[210],"subtype,":[211],"or":[214],"antigens,":[216],"optimizing":[217],"immune-cell":[218],"trafficking":[219],"persistence,":[221],"modifying":[222],"suppressive":[224],"microenvironment,":[225],"longitudinally":[227],"monitoring":[228],"evolution.":[232]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-06T00:00:00"}